Core Viewpoint - Perfect Medical Holdings (01830.HK) experienced a significant stock price drop of 18.7% on June 18, resulting in a market capitalization of HKD 23.49 billion, following a profit warning indicating a projected net profit decline of up to 35% for the fiscal year ending March 31, 2025 [1][2]. Group 1: Financial Performance - The company expects a net profit of HKD 205 million to HKD 210 million for the fiscal year ending March 31, 2025, down from HKD 316 million in the previous year, representing a potential decline of approximately 35% [1][2]. - The primary business operations of Perfect Medical are concentrated in Hong Kong, with over 80% of revenue generated from this region as of September 2024 [2]. Group 2: Market Conditions and Competition - The decline in performance is attributed to the sluggish Hong Kong economy and low consumer sentiment, leading to reduced spending on non-essential services like medical aesthetics [2]. - Increasing competition from Shenzhen and South Korea is impacting Perfect Medical, as local consumers are seeking more cost-effective options, with a notable shift towards these regions for medical aesthetic services [2][3]. Group 3: Strategic Responses - In response to the challenging market conditions, the company is launching high-value Korean medical aesthetic services and enhancing customer loyalty programs to stimulate consumption and improve customer experience [2][3]. - Perfect Medical has signed an exclusive partnership with the Korean medical aesthetic brand Oracle to introduce Korean medical techniques in Hong Kong, while also exploring potential acquisitions of promising medical aesthetic clinics in Shenzhen to capitalize on cross-border consumption opportunities [3].